Kodiak Sciences CEO Victor Perlroth Buys 300,000 Shares at $1.04, Sparking Investor Optimism Ahead of Zenkuda FDA Submission.
CEO Victor Perlroth’s fresh 300k‑share buy at $1.04 boosts Kodiak Sciences’ Phase III Zenkuda hype—signaling confidence, potential upside, and a bullish market outlook.
3 minutes to read